Sensex Ends Near Record High; Realty Stocks Bleed

Thu, 18 Jan Closing

   Previous Close   

   Pre-Open   

   09:30 am   

   11:30 am   

   01:30 pm   

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note. Losses were seen across most sectors with stocks in the telecom sector and stocks in the realty sector leading the losses. Banking stocks, on the other hand, traded in the green.

At the closing bell, the BSE Sensex stood higher by 178 points (up 0.5%) and the NSE Nifty closed up by 28 points (up 0.3%). Most of the selling pressure was seen for the BSE Mid Cap index, which ended the day down 1.7%, and the BSE Small Cap index which ended down by 2%.

Asian stock markets finished on a mixed note. As of the most recent closing prices, the Hang Seng was up by 0.43% and the Shanghai Composite was up by 0.91%. The Nikkei 225 was down by 0.44%. European markets were also trading mixed. The FTSE was down by 0.38%. The DAX stood up by 0.42%, while the CAC 40 was up by 0.17%.

The rupee was trading at Rs 63.83 against the US$ in the afternoon session.

In the news from the pharmaceuticals space, Suven Life Sciences has secured one product patent from China and one product patent from Sri Lanka corresponding to the New Chemical Entities (NCEs). The two patents are valid through 2033 and 2032 respectively.

The granted claims of the patents include the class of selective 5-HT4 and H3 compounds respectively.

These compounds are being developed as therapeutic agents for major depressive disorders and neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively.

One must note that the innovators in the pharmaceutical industry rely heavily on patents. They make heavy use of patents whenever they create a new drug. The patent allows them to recoup the high capital expenditure that goes into the research and development (R&D) of new drugs. Also, companies that have a patent on a particular product are immune from competition for the duration of the patent.

Speaking of pharma companies, the BSE healthcare index was the worst performing sector in 2017. In fact, the sector has underperformed over the past three years.

While 2018 earnings of pharma companies are expected to be better considering the low earnings base in 2017, certain challenges still remain.

The valuations of the top five companies by market capitalization on BSE healthcare remain high. Average Price to Earnings Ratio of the top five companies stands at 36. Considering the headwinds these companies are facing, it certainly seems rich.

Valuations of Top Pharma Companies Still High

https://www.equitymaster.com/5minWrapUp/charts/index.asp?date=01/13/2018&story=1&title=01132018-Valuations-of-Top-Pharma-Companies-Still-High <>

An improved earnings performance in 2017 will certainly get these valuations to reasonable levels, provided the share price remains the same. But, the headwinds for the sector still exists.

2018 looks likely to be another challenging year for the sector. The uncertainties make it important to be stock specific in the sector.

As of today, three stocks in the pharma sector are currently buy worthy according to The India Letter (subscription required). These are the pharma stocks we believe will outlast the others in the long run.

Moving on to the news from commodities space. India's gold imports rose 53% to 846 tonnes in the 2017 fiscal. This came mainly on the back of strong domestic demand and lower global prices.

Reportedly, India is world's second largest gold consumer and had imported 550 tonnes of the metal in 2016.

In December 2017 alone, gold imports rose to 70 tonnes from 49 tonnes in the year-ago period.

Further, global prices of gold remained lower between US$1,200 per ounce and US$1,300 per ounce. Currently, they are ruling higher at above Rs 1,330 per ounce level.

To keep a tab on the movements in gold and other commodities, you can read the stock market commentary from the Daily Profit Hunter team. Their commentary tracks the developments in the global economy as well as stock, currency, and commodity markets.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers